FDA Examination Of Homeopathic Regulation Looks Beyond Safety History
This article was originally published in The Tan Sheet
Executive Summary
CDER Director Janet Woodcock says the current regulatory framework limits FDA’s direct regulation of homeopathics to post-market surveillance. During a two-day public hearing, agency officials question stakeholders about trials, labeling and how well consumers understand their products.